Territory Business Manager

Elutia; United States; On-site; USD 90,000 - 130,000; Full time

Job summary

Elutia is seeking a Territory Business Manager to drive adoption of its regenerative portfolio across assigned territories in the U.S. The role involves building deep relationships with plastic and reconstructive surgeons, guiding accounts from clinical evaluation to VAC approval, and shaping territory strategy ahead of a planned launch in early 2027.

The position offers autonomy and a clear path to expand Elutia's commercial footprint as the company focuses on the $1.5 billion plastic and

Responsibilities

• Build, manage, and grow an assigned territory - including greenfield accounts - leading new accounts from initial clinical evaluation through VAC approval and committed usage.
• Develop and execute a territory business plan that identifies target accounts, surgeons, and hospital systems.

Job description

Each year, more than 150,000 breast reconstruction procedures are performed in the U.S., yet one in three patients still faces a serious complication. That is not good enough. At Elutia, we are working to change it.

Our mission is to humanize medicine so patients can thrive without compromise. We are pioneering drug-eluting technologies to improve the interface between medical devices and the patients who rely on them.

How we work matters just as much as what we make. Elutia is a certified Great Place to Work®, grounded in our CRU values: Contagiously Confident, Ridiculously Relentless, and Unanimously United. We set a high bar for ourselves, for each other, and for the outcomes we deliver.

Our team is All In on the mission. This is not the place for someone looking to coast. It is the place for someone who wants to solve hard problems, move with urgency, and make a real mark on medicine, alongside a team fully committed to improving patient outcomes.

The Territory Business Manager drives adoption of Elutia's regenerative portfolio within an assigned territory, building deep relationships with plastic and reconstructive surgeons and leading new accounts through clinical evaluation, Value Analysis Committee (VAC) approval, and conversion. Following the divestiture of its BioEnvelope business to Boston Scientific, Elutia is concentrating its resources on the $1.5 billion U.S. plastic and reconstructive surgery market, where post-operative infection remains a persistent and costly complication. This role is central to building Elutia's commercial footprint ahead of and following the launch of NXT-41x, a next‑generation antibiotic-eluting biomatrix purpose-built for breast reconstruction that leverages the same drug-delivery technology behind the successful commercial launch of EluPro™. This individual will operate with a high degree of autonomy, representing Elutia in the operating room, in the C-suite, and everywhere in between.

We're proactively building our commercial talent pipeline now, ahead of NXT-41x's planned launch in early 2027 - connect with us today to get on our radar early and help shape territory strategy from the ground up when the role opens.

We are specifically looking for candidates in the following areas:

• Manhattan / Long Island / Boroughs, NY
• Atlanta, GA
• Birmingham, AL
• Washington D.C.
• Chicago, IL
• Miami, FL
• Philadelphia, PA
• Charleston / Greenville, SC

What You'll do:

Territory & Account Development

• Build, manage, and grow an assigned territory - including greenfield accounts - leading new accounts from initial clinical evaluation through VAC approval and committed usage.
• Develop and execute a territory business plan that identifies target accounts, surgeons, and hospital systems.

Clinical & Relationship Impact